Effects of dietary protein restriction on albumin and fibrinogen synthesis in macroalbuminuric type 2 diabetic patients

Diabetologia

Volumn 51, Issue 1, 2008, Pages 21-28

  Giordano, M ^a   Lucidi, P ^b   Ciarambino, T ^a   Gesue L ^a   Castellino, P ^c   Cioffi, M ^a   Gresele, P ^b   Paolisso, G ^a   De Feo, P ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Absolute synthesis; Albumin; Diabetic nephropathy; Fibrinogen; Fractional synthesis; Leucine; Low grade inflammation; Low protein diet; Macroalbuminuria; Type 2 diabetes

Indexed keywords

ALBUMIN; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INTERLEUKIN 6; LEUCINE; PLASMA PROTEIN;

ADULT; ALBUMINURIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; MACROALBUMINURIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTAKE; PROTEIN RESTRICTION; PROTEIN SYNTHESIS; PROTEINURIA; STATISTICAL SIGNIFICANCE;

ADULT; ALBUMINS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIET, PROTEIN-RESTRICTED; DIETARY PROTEINS; FEMALE; FIBRINOGEN; HUMANS; LEUCINE; MALE; MIDDLE AGED; PROTEINURIA; TREATMENT OUTCOME;

EID: 36649032283     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0874-y     Document Type: Article

References (37)

1. American Diabetes Association (2007) Standards of medical care in diabetes-2007. Diabetes Care 30:S1-S41
2. Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH (2004) Progression of nephropathy in type 2 diabetic patients. Kidney Int 66:1596-1605
3. Gall MA, Hougaard P, Borch-Johnsen K, Parving HH (1997) Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ 314:783-788
4. Stehouwer CDA, Gall MA, Twisk JWE, Knudsen E, Emeis JJ, Parving HH (2002) Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes. Progressive, interrelated and independently associated with risk of death. Diabetes 51:1157-1165
5. Tessari PE, Kiwanuka R, Barazzoni M, Vettore M, Zanetti M (2006) Diabetic nephropathy is associated with increased albumin and fibrinogen production in patients with type 2 diabetes. Diabetologia 49:1955-1961
6. Bruno G, Merletti F, Biggeri A et al (2005) Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetologia 48:427-434
7. De Zeeuw D, Remuzzi G, Parving HH et al (2004) Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 65:2309-2320
8. de Mello VDF, Zelmanovitz T, Perassolo MS, Azevedo MJ, Gross JL (2006) Withdrawal of red meat from the usual diet reduces albuminuria and improves serum fatty acid profile in type 2 diabetes patients with macroalbuminuria. Am J Clin Nutr 83:1032-1038
9. de Sain-van der Velden MG, Kaysen GA, de Meer K et al (1998) Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: measurements with stable isotopes. Kidney Int 52:181-188
10. Giordano M, De Feo PP, Lucidi P et al (2001) Effects of dietary protein restriction on fibrinogen and albumin metabolism in nephrotic patients. Kidney Int 60:235-242
11. Fingerhut D (ed) (2007) KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 49(Suppl 2):S17
12. Moulin CC, Tiskievicz F, Zelmanivitz T, Oliveira J, Azevedo MJ, Gross JL (1998) Use of weighed diet records in the evaluation of diets with different protein contents in patients with type 2 diabetes. Am J Clin Nutr 67:853-857
13. Horber FF, Kahl J, Lecavalier L, Krom B, Haymond MW (1989) Determination of leucine and alfa-ketoisocaproic acid concentrations and specific activity in plasma and leucine specific activities in proteins using high-performance liquid chromatography. J Chromatogr 495:81-94
14. Schwenk WF, Berg PJ, Beaufrere B, Miles JM, Haymond MW (1984) Use of t-butyldimethylsilylation in the gas chromatographic/mass spectrometric analysis of physiologic compounds found in plasma using electron-impact ionization. Ann Biochem 141:101-109
15. De Feo P, Volpi E, Lucidi P et al (1995) Ethanol impairs post-prandial hepatic protein metabolism. J Clin Invest 95:1472-1479
16. De Feo P, Volpi E, Lucidi P et al (1993) Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans. Diabetes 42:995-1002
17. Brown MA, Mitar DA, Whitworth JA (1992) Measurement of plasma volume in pregnancy. Clin Sci 83:29-34
18. Doumas BT, Watson WA, Biggs HG (1971) Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 31:87-96
19. Clauss A (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematologica 17:237-246
20. Colucci M, Binetti BM, Branca MG et al (2003) Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis. Hepatology 38:230-237
21. Lott JA, Stephan VA, Pritchard KA (1983) Evaluation of the Coomassie Brilliant Blue G-250 method for urinary protein. Clin Chem 29:1946-1950
22. Scwenk WF, Beaufrere B, Haymond MW (1985) Use of reciprocal pool specific activities to model leucine metabolism in humans. Am J Physiol 249:E646-E650
23. Maroni BJ, Steinman TI, Mitch WE (1985) A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 27:58-65
24. Simonson DC, DeFronzo RA (1990) Indirect calorimetry: methodological and interpretative problems. Am J Physiol 258:399-412
25. Zeller K, Whittaker L, Raskin SP, Jacobson HR (1991) Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 324:78-84
26. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH (1996) The effect of dietary protein restriction on the progression of diabetic and non diabetic renal diseases: a meta-analysis. Ann Int Med 124:627-632
27. Pijls LT, De Vries H, Donker AJ, van Eijk JT (1999) The effect of protein restriction on albuminuria in patients with type 2 diabetes mellitus: a randomized trial. Nephron Dial Transplant 14:1445-1453
28. Hansen HP, Tauber-Lassen E, Jensen BR, Parving HH (2002) Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int 62:220-228
29. Barsotti G, Cupisti A, Barsotti M et al (1998) Dietary treatment of diabetic nephropathy with chronic renal failure. Nephron Dial Transplant 13(Suppl 8):49-52
30. Bologa RM, Levine DM, Parker T et al (1998) Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32:107-114
31. Fogari R, Zoppi A, Lazzari P et al (1998) ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients. J Cardiovasc Pharmacol 32:616-620
32. Persson F, Rossing P, Hovind P et al (2006) Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria. An IRMA 2 Substudy. Diabetes 55:3550-3555
33. Pearson TA, Mensah GA, Alexander RW et al (2003) Markers of inflammation and cardiovascular disease application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499-511
34. Dandona P, Kumar V, Aljada A et al (2003) Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action. J Clin Endocrinol Metab 88:4496-4501
35. Pearson T, Ballantyne C, Sisk C et al (2007) Comparison of effects of ezetimibe/sinvastatin versus sinvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels. Am J Cardiol 99:1706-1713
36. Brodsky IG, Robbins DC, Hiser E, Fuller SP, Fillyaw M, Devlin JT (1992) Effects of low-protein diets on protein metabolism in insulin-dependent diabetes mellitus patients with early nephropathy. J Clin Endocrinol Metab 75:351-357
37. Giordano M, Castellino P, Ohno A, DeFronzo RA (2000) Differential effects of amino acid and ketoacid on protein metabolism in humans. Nutrition 16:15-21